Principal Researcher
Prof. Gideon Gross
Immunology
97246953554
972-4-6944980
We develop new genes for the immunotherapy of human diseases. In the late 80's, together with Z.
Latest Publications
CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens
Front. Immunol., Vol. 15.
2025
Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes
Frontiers in Immunology. 15:1463971
2024
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
Front. Immunol. Sep. 4.
2023
Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy
J. Immunother. Cancer, July 23.
2022